Atlas market file · Equity · United States
QuidelOrtho CorpQDEL
- Last close
- 12.285
- Change
- -24.72%
- 96-bar range
- 9.92 – 19.8
- As of
- 7 Aug 2026
QuidelOrtho Corp is an in vitro & in vivo diagnostic substances issuer listed as QDEL on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
QDEL
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-72.71% over the window).
Source rail: Yahoo Finance chart API (QDEL). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for QDEL. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
QDEL public profile
In vitro & in vivo diagnostic substances issuer. QuidelOrtho Corp is connected to current market context, cited company sources and its retained research file.
QuidelOrtho Corp trades as QDEL on NASDAQ. QuidelOrtho Corp (QDEL) has a latest verified close of 12.285, down 24.72%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files QDEL under USA Stocks for browsing.
What changed for QuidelOrtho Corp today
QuidelOrtho Corp (QDEL) reported a net loss of $91.8M for the quarter ending 2026-03-29, a stark contrast to its polished marketing around its SOFIA™ and SAVANNA™ diagnostic platforms. The company, which specializes in rapid diagnostic testing and molecular solutions, saw revenues of $619.8M but struggled with operating losses of $31.8M and a free cash flow burn of $33.0M. The latest SEC filings reveal significant insider selling, with a board member offloading 5,000 shares at $20.50 each, netting $102,500.
QuidelOrtho’s business revolves around its diagnostic platforms, including the SOFIA™ 2 Analyzer for rapid testing and the SAVANNA™ multiplex PCR testing platform. The company also offers VALUMETRIX™ Lab Consulting Services to optimize lab operations. Despite its innovative product lineup, the company’s financials tell a different story, with a net income loss and a substantial inventory build of $611.5M, indicating potential overproduction or reduced demand.
For the quarter ending 2026-03-29, QuidelOrtho reported revenues of $619.8M, a net income loss of $91.8M, operating income loss of $31.8M, and free cash flow burn of $33.0M. The company’s assets stand at $5.63B, with liabilities of $3.78B and stockholders’ equity of $1.85B. Research and development expenses were $44.9M, and capital expenditures were $34.0M. The company’s earnings per share (diluted) were $-1.35, with a weighted average number of shares outstanding of 68.2M.
For chart and source context, QuidelOrtho’s stock performance can be tracked on TradingView, with the latest filings available on SEC EDGAR. The company’s financial health and market position are critical to monitor, given the significant insider selling and financial losses. The tension between the company’s innovative product lineup and its financial struggles will be a key focus for investors.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
QDEL technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on QDEL
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep QDEL research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
QDEL FAQ
What is QuidelOrtho Corp (QDEL)?QuidelOrtho Corp (QDEL) has a latest verified close of 12.285, down 24.72%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
QuidelOrtho Corp (QDEL) has a latest verified close of 12.285, down 24.72%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for QDEL?QuidelOrtho Corp (QDEL) has a latest verified close of 12.285, down 24.72%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources,...
QuidelOrtho Corp (QDEL) has a latest verified close of 12.285, down 24.72%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files QDEL under USA Stocks for browsing.
How often is the QDEL page updated?The QDEL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The QDEL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for QDEL?The QDEL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:QDEL. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The QDEL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:QDEL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on QDEL?Yes. The workstation can open QDEL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open QDEL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this QDEL page investment advice?No. The QDEL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The QDEL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →